Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment. | ||||||||
|
Twenty-three years of disease-free survival following cutaneous metastasis from a primary bladder transitional cell carcinoma.Gowardhan B, Mathers ME, Feggetter JG Department of Surgery, Medical School, Newcastle University, Newcastle upon Tyne, UK. bharat.gowardhan@ncl.ac.uk We present a case of cutaneous metastases from a primary bladder transitional cell carcinoma (TCC), with a prolonged survival of 23 years. Cutaneous metastases from primary bladder TCC are uncommon and, like all metastases, have a poor prognosis. The common modality of treatment of cutaneous metastases from a primary bladder cancer is wide local excision of the metastases followed by combination chemotherapy. Here, we present a case of a solitary cutaneous metastasis from a primary bladder TCC, which was treated with wide local excision and single agent chemotherapy. Twenty-three years on, the patient remains disease and recurrence free. Published 28 October 2004 in Int J Urol, 11(11): 1031-2.
© 2004-2008 Skin Cancer Research Today. All Rights Reserved. |
| ||||||